Literature DB >> 15604056

[Advanced oxidation protein products induce reactive oxygen species production in endothelial cells].

Fang Yuan1, Shang-xi Liu, Jian-wei Tian.   

Abstract

OBJECTIVE: To investigate the effect of advanced oxidation protein products (AOPP) on production of reactive oxygen species (ROS) in endothelial cells.
METHODS: Human umbilical vein endothelial cell line ECV304 were stimulated with AOPP-modified bovine serum albumin (AOPP-BSA) prepared by oxidation of BSA with HOCl in vitro. ROS production in the cells was evaluated by kinetic measurement of dichlorofluoroscein (DCF) fluorescence produced by oxidation of an oxidant-sensitive dye 2,7-dichlorefluorescin (DCFH) using VICTOR 1420 multilabel counter.
RESULTS: AOPP-BSA could induce ROS production in ECV304 cells time- and dose-dependently, and the quantity of ROS increased with the oxidation degree of BSA. Pretreatment of cells with a small-molecular-mass glutathione peroxidase mimic ebselen or NADPH oxidase inhibitor apocynin inhibited ROS production by 65% and 29% respectively.
CONCLUSION: AOPP-BSA induces ROS production in endothelial cells, partially mediated by NADPH oxidase activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604056

Source DB:  PubMed          Journal:  Di Yi Jun Yi Da Xue Xue Bao        ISSN: 1000-2588


  2 in total

1.  Advanced oxidation protein products from the follicular microenvironment and their role in infertile women with endometriosis.

Authors:  Yali Song; Jing Liu; Zhuolin Qiu; Donghong Chen; Chen Luo; Xiaoning Liu; Rui Hua; Xi Zhu; Yanling Lin; Lina Li; Wenlian Liu; Song Quan
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

2.  1H NMR based targeted metabolite profiling for understanding the complex relationship connecting oxidative stress with endometriosis.

Authors:  Saikat K Jana; Mainak Dutta; Mamata Joshi; Sudha Srivastava; Baidyanath Chakravarty; Koel Chaudhury
Journal:  Biomed Res Int       Date:  2013-08-05       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.